Treats moderate acne vulgaris in females at least 15 years of age. ANDA 200538, held by Glenmark Pharms Ltd. Ethinyl Estradiol; Norgestimate.
As of Nov 16, 2026, ANDA 200538 (Norgestimate And Ethinyl Estradiol), held by Glenmark Pharms Ltd, was first approved by FDA on Apr 5, 2012, with 5 approved supplements and 0 published complete response letters.
Norgestimate and ethinyl estradiol tablets are combinations of norgestimate, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy. Norgestimate and ethinyl estradiol tablets 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg are indicated for the treatment of moderate acne vulgaris in females at least 15 years of age, who have no known contraindications to oral contraceptive therapy and have achieved menarche. Norgestimate and ethinyl estradiol tablets 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control. 1.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 5, 2012 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Norgestimate And Ethinyl Estradiol0.035MG;0.25MG · tablet;oral-28 | Ethinyl Estradiol; Norgestimate | Rx |
| Apr 29, 2022 | Supplement 12Labeling · Standard review | Approved | None posted |
| Jan 28, 2022 | Supplement 5Labeling · Standard review | Approved | None posted |
| Jan 28, 2022 | Supplement 7Labeling · Standard review | Approved | None posted |
| Apr 28, 2015 | Supplement 3Labeling · Standard review | Approved | None posted |
| Mar 28, 2013 | Supplement 2Labeling · Standard review | Approved | None posted |
| Apr 5, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters